miRNA Market Report, Size 2021 by Top Countries Data, Industry Analysis by Regions, Revenue, Share, Development, Tendencies and Forecast to 2027

 The global miRNA Market is expected to exceed the market valuation of more than US$ XX million by 2027 expanding at a reasonable CAGR of XX% during the forecast period (2021-2027). miRNA discovered in humans helps in the regulation of gene expression. Most of the human disease occurs due to genetic changes, hence miRNA is considered to be an important part of clinical diagnostics and therapeutic agents. MicroRNA (miRNA)-based therapeutics can be divided into miRNA mimics and inhibitors of miRNAs (antimiRs). For instance, let-7 miRNA targets various genes such as RAS, MYC, HMGA2, CDC25A, CDK6, cyclin-D2 overexpressed in the case of non-small-cell lung cancer (NSCLC).

For a detailed analysis of the miRNA, market browse through - https://univdatos.com/report/microrna-market

The demand for miRNA is mainly increasing on account of the emerging microRNA (miRNA) tools for disease-associated applications, the high role of miRNA in the target identification and prediction, and the high adoption of miRNA as a potential biomarker. Moreover, the role of miRNA in the diagnosis and treatment of various chronic diseases such as cancer, neurological disease, liver disease, metabolic diseases, and chronic heart diseases is also propelling the market growth. For instance, as per the Centers for Disease Control and Prevention, In the United States, someone has a heart attack every 40 seconds and every year, about 805,000 Americans have a heart attack.

The rise of the COVID-19 has shown a positive impact on the miRNA Market in 2020 and across. Several studies have demonstrated the role of miRNAs in essential mechanisms of cell biology, regulation of the immune system, and the onset and progression of numerous types of disorders. The immune responses to various viral respiratory infections are correlated with the ectopic expression of miRNAs. Alterations of the miRNA expression in epithelial cells may contribute to the pathogenesis of chronic and acute airway infections. Hence, analyzing the role of these types of nucleotides in antiviral immune responses and the characterization of miRNA target genes helps in understanding the mechanisms of the interplay between the host and virus.

For a detailed analysis of the COVID-19 Impact on miRNA browse through - https://univdatos.com/report/microrna-market

Based on Products, the market is fragmented into Instruments and Consumables. The instruments segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period. In the recent few years, there is an increase in the number of miRNA-based clinical trials coupled with the rising incidents of chronic diseases. For instance, as per PubMed, three miRNAs (miR-1, miR-133, and miR-208) are highly expressed in the heart tissues and are significant regulators of myocyte differentiation and development of the heart.

Based on Services, the market is fragmented into Service Type and Specimen. The Service Type segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the rising strategic collaboration between companies for providing microRNA profiling services. For instance, Rosetta Genomics Ltd., a leading developer and provider of microRNA-based and other molecular diagnostics, and Biocept, Inc., a molecular diagnostics company commercializing and developing blood-based liquid biopsies to improve the detection and treatment of cancer, announced the successful completion of feasibility studies under a previously announced collaboration to evaluate the use of Biocept's patented microfluidic channel technology to extract circulating tumor cells (CTCs) from blood and Rosetta Genomics' technical expertise and proprietary qRT-PCR platform to characterize microRNAs isolated from those CTCs.

For a detailed analysis of the Services in miRNA browse through - https://univdatos.com/report/microrna-market

Based on End-user, the market is fragmented into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and other end-users. The Biotechnology & Pharmaceutical Companies segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period due to the emerging miRNA startups. For instance, Strand Therapeutics established in 2018 in the USA is an emerging biopharmaceutical company applying synthetic biology to RNA therapeutics and developing the first platform for the creation of programmable, long-acting mRNA drugs capable of delivering precise, multi-functional, potentially curative treatments with a single dose.

Request for Sample of the report browses through - https://univdatos.com/request_form/form/484

For a better understanding of the market adoption of miRNA, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the MiRNA market on account of the rising number of clinical trials for the development of novel therapeutics, and the increase in recent product launches in the region.  Some of the major players operating in the market include Merck KGaA, Thermo Fisher Scientific, Inc., Horizon Discovery Ltd., Synlogic, QIAGEN, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString, and BioGenex. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Global miRNA Market Segmentation

Market Insight, by Products  

•       Instruments

•       Consumables

Market Insight, by Services

•       Service Type

•       Specimen

Market Insight, by Application

•       Cancer

•       Infectious Diseases

•       Immunological Disorder

•       Cardiovascular Disease

•       Neurological Disease

•       Others

Market Insight, by End-user

•       Biotechnology & Pharmaceutical Companies

•       Academic & Government Research Institutes

•       Other end-users

Market Insight, by Region

·       North America

o   United States

o   Canada

o   Rest of North America

·       Europe

o   France

o   Germany

o   Italy

o   Spain

o   United Kingdom

o   Rest of Europe

·       Asia-Pacific

o   China

o   Japan

o   India

o   Australia

o   Rest of Asia-Pacific

·       Rest of World

Top Company Profiles

·       Merck KGaA

·       Thermo Fisher Scientific, Inc.

·       Horizon Discovery Ltd.

·       Synlogic

·       QIAGEN

·       GeneCopoeia, Inc.

·       New England Biolabs

·       Quantabio

·       NanoString

·       BioGenex